to experience the full functionality of mail.com.
Can't access your account?
Keep me logged in!
Enhanced by Google
Johnson & Johnson
November 20, 2015
FDA approves Takeda drug for blood cancer multiple myeloma
The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.
November 16, 2015
Johnson & Johnson multiple myeloma drug wins accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple ...
November 03, 2015
J&J, ViiV: 2 injections every month or 2 could control HIV
Preliminary testing of two long-acting injectable drugs indicates it might be possible to keep HIV at bay indefinitely with ...
October 22, 2015
FDA warns of deadly liver damage with AbbVie hepatitis drugs
Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening ...
October 20, 2015
Why optimism about the US economy's strength has dimmed
Consumers, fueled by job growth, cheaper gas and higher home values, would drive the U.S. economy through a global slump.
October 19, 2015
Johnson & Johnson: Stelara fares well in Crohn's disease
Johnson & Johnson's immune disorder drug Stelara significantly reduced symptoms of the inflammatory bowel condition Crohn's ...
October 13, 2015
Johnson & Johnson posts mixed 3Q results, authorizes buyback
Johnson & Johnson, continuing a tough year of declining revenue, posted a 29 percent drop in third-quarter earnings as it was ...
October 09, 2015
Johnson & Johnson starts Ebola vaccine trial in Sierra Leone
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study ...
September 21, 2015
Biotech stocks fall on Clinton vow to fight 'price gouging'
Stocks of makers of biologic and "specialty" drugs plunged Monday after Democratic presidential frontrunner Hillary Clinton ...
September 17, 2015
Study: Type 2 diabetes pill Jardiance cuts risk of death
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making ...
August 27, 2015
Contact lens makers take fight over price law to court
Contact lens makers struggled Thursday to defend their pricing policies in a federal appeals case that could have ...
July 30, 2015
Brilinta? Brintellix? FDA warns of drug name mix-ups
The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the similar names of ...
July 14, 2015
Johnson & Johnson edges Street views with weak 2Q
Johnson & Johnson's recovering U.S. consumer health business, following years of recalls that kept Tylenol, Motrin and other ...
July 14, 2015
Turning to earnings: investors hope results can lift stocks
After fretting over a Greek bailout, a collapse in Chinese stocks and the timing of an interest rate increase, investors are ...
July 14, 2015
A mixed start for stocks as investors focus on sales drop
U.S. stocks are off to a sluggish start as investors turn their focus to a weak retail sales and corporate earnings news.
July 13, 2015
Asia stocks lifted by Greece deal, China's 4th day of gains
Asian stock markets were mostly higher Tuesday after Greece and its European creditors agreed on a bailout and Chinese shares ...
June 13, 2015
Discount contact lens retailers given OK to lower prices
Discount contact lens sellers scored a legal victory in an increasingly bitter pricing war with manufacturers as a federal ...
June 12, 2015
Court allows hotly disputed discount contact lens price law
A federal appeals court ruling has cleared the way for discount contact lens retailers to drop prices while a legal battle ...
June 11, 2015
Johnson & Johnson starts project to prevent Type 1 diabetes
Johnson & Johnson has begun a research partnership to find the root cause of Type 1 diabetes and stop the hormonal disorder ...
June 05, 2015
Cardinal Health paying $1.1B for pharmaceutical distributor
Cardinal Health will spend about $1.12 billion to buy pharmaceutical distributor The Harvard Drug Group in a deal that aims ...